Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300463.SZ

SELLREMOVE

Maccura Biotechnology Co.Ltd · Healthcare · China · $845M · Avg Vol: $9M/d

33
StockRank
Q
49
V
36
M
41
P/E (TTM)
—
ROE
-0.9%
D/E
0.2x
Dividend %
—
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →
AI CONVICTION THESIS

Lacks alignment with core macro themes and exhibits weak quality metrics, making it unsuitable for a highly concentrated portfolio.

COMPANY DESCRIPTION

Maccura Biotechnology Co., Ltd. researches, manufactures, and distributes in-vitro diagnostic (IVD) instruments and reagents. The company offers a comprehensive product portfolio spanning chemiluminescence immunoassay, clinical chemistry, hematology, and molecular diagnostics. Its competitive moat is established through its extensive domestic distribution network and continuous R&D in high-throughput automated laboratory systems.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue533M428M377M321M-15.6%
EPS0.170.080.03-0.01-57.8%
Shares612M612M612M605M-1.3%
Debt104M98M97M140M10.5%
Equity930M944M941M927M-0.1%
Op CF125M133M94M89M-10.6%
Inv CF-270M-74M-100M-107M—
Fin CF137M-23M-19M21M—
Loading...
PRICE (1M)-21.7%
1.241.341.451.551.66May 8May 29Jun 18
SMA 50SMA 200
Close
$1.24
RSI (14)
20.9
52W High
$2.10
From 52W High
0.6%

SCORE BREAKDOWN

Quality
49
ROIC
-1.1%42.9
ROE
-0.9%43.6
GP/Assets
15.0%35.4
Op. Margin
4.3%52.9
FCF/Assets
1.0%54.5
Piotroski
—55.7
Int. Cover
-3.6x31.8
D/E Ratio
0.15x58.0
Current Ratio
3.16x55.6
Value
36
P/E (TTM)
—N/A
EV/EBITDA
17.1x23.4
P/FCF
469.8x17.5
P/B
0.8x83.2
P/S
2.4x61.8
Div Yield
—N/A
Momentum
41
52W High %
59%38.4
RS 6M
-36%34.8
SMA 50/200
0.88x30.0
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—98.9
Q Growth
-63%6.3

FUNDAMENTALS

Market Cap
$845M
P/E (Forward)
9.9x
Gross Margin
56.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300463.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
300463.SZMaccura Biotechnology Co.Ltd(you)$845M33SELL
603716.SSThalys Medical Technology Group Corporation$568M31SELL
9860.HKAdicon Holdings Limited$394M32SELL
603108.SSShanghai Runda Medical Technology Co., Ltd.$1.1B21SELL
2427.HKGuanze Medical Information Industry (Holding) Co., Ltd.$526M42HOLD
300676.SZBGI Genomics Co., Ltd.$2.3B37HOLD
3347.HKHangzhou Tigermed Consulting Co., Ltd$3.4B41HOLD
603882.SSGuangzhou Kingmed Diagnostics Group Co., Ltd.$1.8B67BUY
300685.SZAmoy Diagnostics Co., Ltd.$1.2B80BUY
300406.SZBeijing Strong Biotechnologies,Inc.$1.0B86STRONG BUY

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.0%

Maccura Biotechnology Co.Ltd (300463.SZ) — Stock Score Summary

Maccura Biotechnology Co.Ltd (300463.SZ) has a MoatMap StockRank of 33/100 based on Quality (49/100), Value (36/100), and Momentum (41/100) factor scores. The current signal is SELL. Lacks alignment with core macro themes and exhibits weak quality metrics, making it unsuitable for a highly concentrated portfolio.

Maccura Biotechnology Co., Ltd. researches, manufactures, and distributes in-vitro diagnostic (IVD) instruments and reagents. The company offers a comprehensive product portfolio spanning chemiluminescence immunoassay, clinical chemistry, hematology, and molecular diagnostics. Its competitive moat is established through its extensive domestic distribution network and continuous R&D in high-throughput automated laboratory systems.

Key Financial Metrics

Price$1.24
Market Cap$845M
P/E (Forward)9.92
Price/Book0.83
Return on Equity-0.9%
Return on Invested Capital-1.1%
Debt/Equity15.44
Gross Margin56.1%
Operating Margin4.3%
Revenue Growth-6.9%
Free Cash Flow$2M

Maccura Biotechnology Co.Ltd operates in the Diagnostics & Research industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Maccura Biotechnology Co.Ltd’s (300463.SZ) StockRank?
MoatMap’s StockRank for Maccura Biotechnology Co.Ltd (300463.SZ) is 33/100, with a Sell signal. It is a composite of Quality (49), Value (36), and Momentum (41) factor ranks across MoatMap’s 20,000+ stock universe.
Does Maccura Biotechnology Co.Ltd have an economic moat?
Maccura Biotechnology Co.Ltd (300463.SZ) has a Quality factor score of 49/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Maccura Biotechnology Co.Ltd a buy, hold, or sell?
MoatMap’s current signal for Maccura Biotechnology Co.Ltd (300463.SZ) is Sell, based on a StockRank of 33/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Maccura Biotechnology Co.Ltd in?
Maccura Biotechnology Co.Ltd (300463.SZ) operates in the Healthcare sector, specifically the Diagnostics & Research industry (China).
Browse all ranked stocks300463.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock